Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
NASDAQ:PACB
Price:
2.02 USD
-7.76%
Market Closed
Updated:
May 18, 2024
Pacific Biosciences of California Inc
Pre-Tax Income
|
Pacific Biosciences of California Inc
Pre-Tax Income Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
Pre-Tax Income
-$308.3m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-15%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Pre-Tax Income
$6.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
|
Danaher Corp
NYSE:DHR
|
Pre-Tax Income
$9.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
25%
|
CAGR 10-Years
11%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Pre-Tax Income
$967.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Pre-Tax Income
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
21%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Pre-Tax Income
$1.5B
|
CAGR 3-Years
58%
|
CAGR 5-Years
35%
|
CAGR 10-Years
16%
|
See Also
What is Pacific Biosciences of California Inc's Pre-Tax Income?
Pre-Tax Income
-308.3m
USD
-308.3m
USD
Based on the financial report for Mar 31, 2024, Pacific Biosciences of California Inc's Pre-Tax Income amounts to -308.3m USD.
What is Pacific Biosciences of California Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-15%
-15%
Over the last year, the Pre-Tax Income growth was 4%. The average annual Pre-Tax Income growth rates for Pacific Biosciences of California Inc have been -73% over the past three years , -23% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
